SATB2 and familial pancreatic carcinoma: In the same study, the tissue-specific expression of SATB2 was further confirmed by extended analysis of tumours from several other major cancer forms, where SATB2 expression was either completely lacking, for example, in prostate, gastric and pancreatic cancer, or sparsely expressed, for example, in breast, ovarian and lung cancer (Magnusson et al, 2011).